Medication info
Anapergi 5/80 mg

Anapergi 5/80 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
Aju Pharmaceutical Co., Ltd.
Appearance
Dark yellow round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201308564 · Approved 2013.07.31 · Insurance code 654004340

Summary

Main use
Treatment of essential hypertension not adequately controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Aju Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with monotherapy

  • Essential hypertension
View approved original text

This medication can effectively manage blood pressure in patients with essential hypertension where blood pressure control with amlodipine and valsartan alone is insufficient. In other words, it helps improve hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not controlled with monotherapy using either individual component, switching directly to this medicine may be considered as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication can cause serious harm to a fetus or newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with known allergic reactions to this medication, severely impaired kidney or liver function, pregnant or breastfeeding women should not take this medication. Patients with low body sodium or fluid levels should stabilize their condition before taking this medication; if symptoms of hypotension occur during treatment, they should lie down and rest immediately and seek medical attention if necessary. Patients with elevated potassium levels should be cautious when taking potassium supplements or potassium-rich substances in conjunction with this medication and should have their serum potassium levels regularly monitored. Patients with renal vascular issues or those who have recently undergone kidney transplants should use this medication cautiously due to the risk of renal function deterioration. This medication may cause a serious side effect known as angioedema; if swelling of the face, lips, or tongue occurs, discontinue use immediately and consult healthcare professionals. Patients with heart failure or myocardial infarction should frequently check their renal function and blood pressure while on this medication, as symptoms such as pulmonary edema may arise. As a hypertension treatment, side effects such as headache, dizziness, edema, fatigue, palpitations, cough, and indigestion may occur while taking this medication. Be cautious of dizziness or fatigue while driving or operating machinery, particularly when first starting treatment or altering the dosage. Drug interactions may occur when taking other antihypertensive medications, potassium supplements, diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), heart medications, etc.; thus, it’s essential to inform the physician and undergo regular checks. Women who are pregnant or planning to become pregnant should not use this medication, and it is advisable for breastfeeding women to avoid it as well. Safety and efficacy in pediatric patients under 18 years have not been adequately established; therefore, its use is not recommended. In case of overdose, there may be hypotension, dizziness, or shock; immediate medical attention should be sought. During treatment with this medication, routine liver and renal function tests should be conducted, and if any abnormal symptoms appear, healthcare professionals should be consulted immediately.

Side effects

Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-induced dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle spasm, weakness, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenic syndrome, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory reduction, taste disturbances, peripheral neuropathy, muscle tension dysregulation, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, indigestion, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary dysfunction, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervous irritability, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, at room temperature between 1 to 30 degrees Celsius. Proper storage preserves the efficacy of the medication and ensures safe use.

Appearance and packaging

Appearance

Dark yellow round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.